Silver Wound Dressings Market By Product Type, By Treatment, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Sheets
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Gels and Creams
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.3.4 Gels and Creams Silver Wound Dressings Market by Type
4.4 Foams
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country

CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Surgical Wounds
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Burns
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Ulcers
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Lacerations and Cuts
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Skin Grafts
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
5.7 Others
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market share analysis by country

CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Homecare
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country

CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Treatment
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Treatment
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Treatment
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Treatment
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Treatment
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Treatment
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Treatment
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Treatment
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Treatment
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Treatment
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Treatment
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Treatment
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Treatment
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Treatment
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Treatment
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Treatment
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Treatment
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Treatment
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Treatment
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Treatment
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Treatment
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Treatment
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Treatment
7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 3M Company
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Argentum Medical LLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 , B Braun Melsungen AG
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Convatec, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Ferris Mfg. Corp
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson And Johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Monlycke Health Care
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Mölnlycke Health Care
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 medline industries, inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 DermaRite Industries, LLC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Silver Wound Dressings Market,' the Silver Wound Dressings Market Size was valued at $889.1 million in 2021 and is estimated to reach $1, 511.8 million by 2031, growing at a CAGR of 5.4% from 2022 to 2031.

Silver dressings are wound care products derived from ionic silver. These products release a steady amount of silver to the wound and provide antimicrobial or antibacterial action. Silver dressings may be used as primary or secondary dressings to manage minimal, moderate, or heavy exudate in acute and chronic wounds, including burns, surgical wounds, diabetic foot ulcers, pressure ulcers, and leg ulcers. It provides a broad range of antimicrobial activity, reduces infection, and alters metalloproteinases within wounds.

The Silver Wound Dressings Market Trends are the increase in the prevalence of sport-related injuries, road accidents, and the rise in the geriatric population. Moreover, the increase in the incidence and prevalence of chronic diseases (such as cancers and cardiovascular disease including heart disease, stroke, type II diabetes, and others), has resulted in the rise of the adoption of silver wound dressing in, cardiovascular surgeries, cancer-related surgeries, and others, are the key factors anticipated the growth of the market. For instance, according to a research article published by the National Institute of Medicine, about 21% of the elderly in India reportedly have at least one chronic disease out of which 17% elderly in rural areas and 29% in urban areas suffer from a chronic disease. Thus, a rise in the incidence of chronic diseases is expected to boost the demand for these products, thereby propelling the growth of the market.

However, the high cost of silver wound care products is the major factor projected to hinder the growth of the market.

On the basis of product type, the silver wound dressings market is segmented into sheets, gels & creams, foams, and others. In 2021, the creams & gels segment accounted for the largest Silver Wound Dressings Market Share. The dominance of the segment is attributed to rising in the number of burns and ulcer cases across the world.

On the basis of treatment, the market is classified into ulcers, skin grafts, lacerations & cuts, surgical wounds, burns, and others. In 2021, the surgical wound segment exhibited the highest growth and is anticipated to lead the market during the forecast period, owing to a surge in the number of surgical procedures across the world.

By end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and home care. In 2021, the hospital & clinics segment exhibited the highest growth and is anticipated to lead the market during the forecast period, owing to an increase in the number of patients visiting the facilities for the treatment of acute and chronic wounds across the world.

North America accounted for a majority of the surgical wound dressings market share in 2021 and is anticipated to remain dominant during the forecast period owing to the high adoption rate of technologically advanced products, increase in healthcare expenditure, and the presence of major key players involved in the R&D activities.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. The market growth in the Asia-Pacific region is supplemented by a rise in population in the countries like India and China, the high prevalence rate of road accidents, and prevalence of the chronic disease. In addition, an increase in patient awareness about the beneficial properties of silver-incorporated dressings such as their antimicrobial nature, reduction in healing time, and low infection risk are expected to further drive the Silver Wound Dressings Market Growth.

The key players that operate in the Wound Dressings Industry include 3M (Acelity Inc.) Medline Industries, LP, Argentum Medical LLC, B. Braun Melsungen AG, Convatec Inc, Dermarite Industries, Inc, Ferris Mfg. Corp., Ltd., Johnson and Johnson, Molnlycke Health Care AB, and Smith and Nephew PLC.

Key findings of the study

By product type, the creams & gels segment was the highest contributor to the market in 2021.

By treatment, the surgical wounds segment was the highest contributor in 2021.

By end users, hospitals & clinics dominated the market in 2021 and are expected to continue this trend during the forecast period.

By region, North America held the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

• 3M Company
• Argentum Medical LLC
• , B Braun Melsungen AG
• Convatec, Inc.
• Ferris Mfg.Corp
• Johnson and Johnson
• Monlycke Health Care
• Mölnlycke Health Care
• Medline Industries, Inc.
• Dermarite Industries, LLC.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.